Corbus Pharmaceuticals Holdings, Inc. Earnings Per Share, Basic and Diluted
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Earnings Per Share, Basic and Diluted of -$0.11 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-09
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.11.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.08.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.02.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.15.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.37.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.42.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.12.
- Corbus Pharmaceuticals Holdings, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.11 10-Q · filed 2022-08-09 | -$0.18 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | -$0.08 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | -$0.37 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$0.02 10-Q · filed 2021-11-12 | -$0.29 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-09 | -$0.28 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.14 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$1.42 10-K · filed 2022-03-08 | |||
| 2020-09-30 | -$0.43 10-Q · filed 2021-11-12 | -$1.37 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.52 10-Q · filed 2021-08-12 | -$0.95 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$0.43 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$1.12 10-K · filed 2021-03-15 | |||
| 2019-09-30 | -$0.32 10-Q · filed 2020-11-09 | -$0.71 10-Q · filed 2020-11-09 | ||
| 2019-03-31 | -$0.43 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$0.98 10-K · filed 2020-03-16 | |||
| 2018-09-30 | -$0.26 10-Q · filed 2019-11-07 | -$0.67 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$0.21 10-Q · filed 2018-08-08 | -$0.42 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | -$0.21 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$0.20 10-K · filed 2018-03-12 | -$0.65 10-K · filed 2019-03-12 | ||
| 2017-09-30 | -$0.14 10-Q · filed 2018-11-08 | -$0.44 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$0.15 10-Q · filed 2018-08-08 | -$0.31 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$0.16 10-K · filed 2018-03-12 | |||
| 2016-12-31 | -$0.17 10-K · filed 2018-03-12 | -$0.49 10-K · filed 2018-03-12 | ||
| 2016-09-30 | -$0.12 10-K · filed 2018-03-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.31 10-Q · filed 2017-11-08 | -$0.38 derived: net income ÷ weighted average shares · filed 2018-03-12 |
| 2016-06-30 | -$0.11 10-K · filed 2018-03-12 | -$0.19 10-Q · filed 2017-08-09 | -$0.25 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.32 derived: net income ÷ weighted average shares · filed 2018-03-12 |
| 2016-03-31 | -$0.08 10-K · filed 2018-03-12 | -$0.14 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.30 derived: net income ÷ weighted average shares · filed 2018-03-12 |
| 2015-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.22 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.28 10-K · filed 2018-03-12 |
| 2015-09-30 | -$0.06 10-Q · filed 2016-11-10 | -$0.16 derived: net income ÷ weighted average shares · filed 2016-11-10 | -$0.22 10-Q · filed 2016-11-10 | |
| 2015-06-30 | -$0.10 10-Q · filed 2016-08-12 | -$0.16 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | -$0.06 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | -$0.13 10-K · filed 2016-03-28 | |||
| 2014-09-30 | -$0.03 10-Q · filed 2015-11-10 | -$0.07 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | -$0.02 10-Q · filed 2015-08-13 | -$0.04 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | -$0.02 10-Q · filed 2015-05-13 | |||
| 2013-12-31 | -$0.09 10-K · filed 2015-02-10 | |||
| 2013-09-30 | -$0.01 10-Q · filed 2014-11-13 | -$0.04 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |